Bicocca Open Archive

Logo unimib boa
PUOTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.097
AS - Asia 13.942
EU - Europa 8.620
SA - Sud America 2.280
Continente sconosciuto - Info sul continente non disponibili 1.015
AF - Africa 331
OC - Oceania 13
Totale 46.298
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.667
SG - Singapore 5.134
IT - Italia 2.861
VN - Vietnam 2.419
HK - Hong Kong 2.186
CN - Cina 1.931
RU - Federazione Russa 1.754
BR - Brasile 1.731
CA - Canada 1.136
SE - Svezia 788
IE - Irlanda 778
DE - Germania 717
BD - Bangladesh 545
FR - Francia 391
GB - Regno Unito 343
IN - India 322
ID - Indonesia 245
AT - Austria 205
AR - Argentina 199
KR - Corea 186
FI - Finlandia 180
IQ - Iraq 154
NL - Olanda 139
UA - Ucraina 138
TR - Turchia 128
MX - Messico 121
EC - Ecuador 107
PK - Pakistan 100
ZA - Sudafrica 93
JP - Giappone 87
ES - Italia 81
SA - Arabia Saudita 77
PH - Filippine 70
CO - Colombia 63
PL - Polonia 59
UZ - Uzbekistan 54
VE - Venezuela 52
JM - Giamaica 43
CR - Costa Rica 39
MY - Malesia 39
PY - Paraguay 37
MA - Marocco 34
KE - Kenya 33
TN - Tunisia 32
EG - Egitto 30
AE - Emirati Arabi Uniti 28
ET - Etiopia 28
CL - Cile 25
JO - Giordania 24
PE - Perù 24
OM - Oman 23
CZ - Repubblica Ceca 22
HN - Honduras 21
NP - Nepal 20
IL - Israele 19
UY - Uruguay 19
BO - Bolivia 18
DZ - Algeria 18
KZ - Kazakistan 18
IR - Iran 17
LB - Libano 17
BE - Belgio 16
CH - Svizzera 16
LT - Lituania 15
AZ - Azerbaigian 14
TH - Thailandia 13
GR - Grecia 12
KG - Kirghizistan 12
BG - Bulgaria 11
DK - Danimarca 11
DO - Repubblica Dominicana 11
NG - Nigeria 11
PT - Portogallo 11
AL - Albania 10
HU - Ungheria 10
NI - Nicaragua 10
PS - Palestinian Territory 10
TT - Trinidad e Tobago 10
AU - Australia 9
EE - Estonia 8
PA - Panama 8
SN - Senegal 8
TW - Taiwan 8
BH - Bahrain 7
BY - Bielorussia 7
KW - Kuwait 7
RO - Romania 7
CI - Costa d'Avorio 6
GH - Ghana 6
MU - Mauritius 6
SV - El Salvador 6
GT - Guatemala 5
MD - Moldavia 5
AO - Angola 4
CY - Cipro 4
GE - Georgia 4
GY - Guiana 4
HR - Croazia 4
KH - Cambogia 4
LY - Libia 4
Totale 45.203
Salva come PNG Salva come JPEG
Città #
Singapore 2.914
Hong Kong 2.162
Ashburn 1.889
San Jose 1.661
Ann Arbor 1.097
Toronto 910
Milan 804
Dublin 769
Ho Chi Minh City 742
New York 629
Hanoi 596
Fairfield 593
Council Bluffs 487
Chandler 479
Chicago 466
Santa Clara 462
Dallas 459
Houston 437
Los Angeles 427
Frankfurt am Main 421
The Dalles 399
Hefei 393
Woodbridge 387
Princeton 385
Wilmington 296
Rome 269
Seattle 260
Lauterbourg 247
Beijing 232
Buffalo 199
Cambridge 197
Altamura 193
Lawrence 187
Seoul 177
Moscow 167
Jakarta 160
São Paulo 148
Jacksonville 129
Nuremberg 118
San Diego 115
Vienna 114
Phoenix 113
Dearborn 103
Atlanta 90
Helsinki 87
Shanghai 87
Haiphong 80
Da Nang 78
Tokyo 76
Brooklyn 74
London 73
Orem 73
Columbus 72
Boardman 65
Andover 64
Denver 64
Baghdad 61
Montreal 59
Naples 58
Turin 55
Salt Lake City 54
Figino 52
Tashkent 52
Munich 51
Philadelphia 47
Rio de Janeiro 47
Biên Hòa 45
Dong Ket 45
Warsaw 43
Lappeenranta 42
Nanjing 42
Tampa 42
Guangzhou 41
Ha Long 41
San Francisco 41
Bologna 40
Chennai 39
Washington 39
Elk Grove Village 35
Hải Dương 35
Quito 35
Guayaquil 34
Dhaka 33
Johannesburg 33
Quận Bình Thạnh 33
Stockholm 33
Amsterdam 32
Brasília 31
Florence 31
Lahore 31
Falls Church 30
Miami 30
San José 30
Curitiba 29
Mumbai 29
Jeddah 28
Lachine 28
New Delhi 28
Palermo 28
Belo Horizonte 27
Totale 26.094
Salva come PNG Salva come JPEG
Nome #
EASL recommendations on treatment of hepatitis C: Final update of the series☆ 1.007
Sexually Transmitted Hepatitis 498
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons 395
24-Hour Blood Pressure Monitoring Patterns in HIV-Positive Patients and its Relationship with Arterial Distensibility 386
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 354
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy 336
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 327
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy 313
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 312
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 307
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 299
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 292
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management 288
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: Results from the Icona Foundation study 282
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 277
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 277
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-Clinical Management of HIV-1 Infected Persons 262
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 262
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 261
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 259
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 257
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 257
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 257
Multiple concomitanti infezioni opportunistiche e linfomi aggressivi in una persona con HIV/AIDS che non assumeva la terapia ant 255
Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program 253
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 253
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study 246
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 245
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 242
Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis c coinfection: Data from the ICONA foundation cohort 241
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2 240
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 237
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 235
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 233
Challenges and opportunities for hepatitis B virus screening in people attending PrEP services: a retrospective prevalence study 231
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 231
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 231
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 229
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy 229
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement 226
24 HOUR ARTERIAL DISTENSIBILITY IS RELATED WITH ABPM NON-DIPPING PATTERN IN HIVPOSITIVE PATIENTS 225
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 225
COVID-19 in liver transplant candidates: Pretransplant and post-transplant outcomes - An ELITA/ELTR multicentre cohort study 225
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi 223
Sex differences in electrolyte imbalances caused by SARS-CoV-2: A cross-sectional study 222
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection 218
24-hours arterial distensibility is related with ABPM non-dipping pattern in HIV-positive patients 218
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 215
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 215
Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection 215
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 214
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 213
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients 212
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 210
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 210
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 210
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 210
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 210
Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis [Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne] 209
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients 209
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 208
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement 206
Factors Influencing Depression Endpoints Research (FINDER): Baseline results of Italian patients with depression 206
Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults 205
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 203
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons 203
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 202
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration 200
HIV-positive to HIV-positive liver transplantation: To be continued 200
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy 200
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 200
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 198
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 198
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference 197
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 194
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 193
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 192
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 191
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 190
Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individuals 189
HEFFICON: HIV effectiveness Italian conference 189
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study) 188
Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIV 187
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 187
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm 186
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation 184
A case of chronic bacterial prostatitis due to Mycoplasma genitalium 184
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 183
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 182
Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients 182
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014 181
Prophylaxis and treatment of hepatitis B in immunocompromised patients 180
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 179
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 177
A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969–1989 birth-cohort 177
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 177
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 175
Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: Results from a cross-sectional survey on 7,014 workers in healthcare 175
Trends in all-cause mortality of hospitalized patients due to SARS-CoV-2 infection from a monocentric cohort in Milan (Lombardy, Italy) 173
Phyllanthus niruri versus Placebo for Chronic Hepatitis B Virus Infection: A Randomized Controlled Trial 172
Totale 23.723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 169.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.605
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.399 0 0 0 174 85 120 44 273 125 101 89 388
2022/20232.627 467 752 231 174 113 433 24 140 165 24 71 33
2023/20242.592 55 63 79 70 344 600 445 55 297 48 101 435
2024/20258.480 516 1.159 431 382 664 341 418 216 899 1.270 819 1.365
2025/202620.936 2.454 1.745 1.474 1.905 1.981 939 2.577 977 1.446 1.607 1.945 1.886
2026/20275.815 1.321 1.138 2.422 934 0 0 0 0 0 0 0 0
Totale 46.298